All Stories

  1. TMLRpred: A machine learning classification model to distinguish reversible EGFR double mutant inhibitors

    Article • Chemical Biology & Drug Design, September 2020, Wiley

    Dr Subhash Mohan Agarwal, Shehnaz Fatima

  2. Structure-activity Relationship Study on Therapeutically Relevant EGFR Double Mutant Inhibitors

    Article • Medicinal Chemistry, January 2020, Bentham Science Publishers

    Dr Subhash Mohan Agarwal, Shehnaz Fatima

  3. Exploring structural features of EGFR–HER2 dual inhibitors as anti-cancer agents using G-QSAR approach

    Article • Journal of Receptors and Signal Transduction, May 2019, Taylor & Francis

    Dr Subhash Mohan Agarwal, Shehnaz Fatima

  4. Unraveling structural requirements of amino-pyrimidine T790M/L858R double mutant EGFR inhibitors: 2D and 3D QSAR study

    Article • Journal of Receptors and Signal Transduction, July 2018, Taylor & Francis

    Dr Subhash Mohan Agarwal, Shehnaz Fatima